Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #701621

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	745 792 SEK	1 305 SEK	1 262 837 SEK	—	527 039 SEK	—	8 688 SEK	—	—	—	—	641 250 SEK	1 262 837 SEK	8 688 SEK	—	448,000 SEK	—	—	—	630 723 SEK	– SEK	705 278 SEK	244 876 SEK	463 220 SEK	2 818 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	—	—	—	104 542 SEK	—	178 024 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	—	—	—	—	—	—	—	—	- SEK	—	- SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	—	—	—	– SEK	—	– SEK	—	– SEK	104 542 SEK	104 542 SEK	178 024 SEK	—	—	—	178 024 SEK	—	– SEK	– SEK	– SEK	—	—	—	—	—	—
Issue of equity	—	—	—	—	—	—	—	—	—	—	250 750 SEK	—	—	—	– SEK	—	– SEK	248 236 SEK	2 514 SEK	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	—	857,000 SEK	—	– SEK	—	– SEK	857,000 SEK	– SEK	448,000 SEK	—	—	—	– SEK	—	448,000 SEK	– SEK	– SEK	—	—	—	—	—	—